Search Tag: STOP-HF trial

Cardiology Management

Stop-hf-gene-therapy-sdf-1-remodels-hearts-of-high-risk-patients

2015 25 May

In a late-breaking trials session at Heart Failure 2015, Dr. Marc Penn, a cardiologist at Summa Cardiovascular Institute in Akron, Ohio, U.S., announced that the gene therapy SDF-1 remodelled the hearts of high risk heart failure patients in the phase II STOP-HF trial. Heart Failure 2015 is the main annual meeting of the Heart Failure Association (HFA) of...Read more